Statins and prostate cancer
This article was originally published in The Tan Sheet
Executive Summary
Statin use was associated with a 62% reduction in risk of prostate cancer after adjusting for risk factors, according to a case-control study published in the American Journal of Epidemiology Aug. 15. The risk reduction was especially notable for more aggressive forms of the disease, Jackilen Shannon, Oregon Health & Sciences University, et al., stated. The authors compared statin use in 100 prostate cancer patients with use of the drug in 202 matched controls. Among the cancer patients, 36% had a record of statin use, compared to almost 50% in the control group....